- Clinical significant macular oedema in DM 2nd typePublication without faculty affiliation
- Insulin treatment of type 2 diabetes mellitus2012 | First Faculty of Medicine
- Obesity in pathogenesis of diabetes type 22009 | First Faculty of Medicine
- Clinical characteristics of Type 2 diabetes2009 | First Faculty of Medicine
- Clinical characteristics of Type 2 diabetes2009 | Publication without faculty affiliation
- Obesity in pathogenesis of diabetes type 22009 | Publication without faculty affiliation
- Diabetes mellitus2000 | Publication without faculty affiliation
- Dapagliflozin and its position in DM 2 treatment2017 | Faculty of Medicine in Pilsen
- Možnost ovlivnění inzulinové rezistence a KV komplikací u pacientů s DM 2. typu v klinické praxi2020 | First Faculty of Medicine
- New guidelines for management od type 2 DM2007 | Second Faculty of Medicine
- Doporučení pro léčbu DM 2. typu v ordinaci praktického lékaře2019 | First Faculty of Medicine
- Studie VERIFY: srovnání časné kombinace metformin/vildagliptin s monoterapií metforminem aneb máme další důvod přepisovat doporučení léčby DM 2. typu?2019 | First Faculty of Medicine
- Must the start of insulin treatment in type 2 diabetes be connected with increasing of their body weight?2012 | Second Faculty of Medicine
- Treatment of dyslipidemia typical for the patients with metabolic syndrom and DM type 22005 | Publication without faculty affiliation
- Treatment of dyslipidemia typical for the patients with metabolic syndrom and DM type 2 +12005 | Faculty of Medicine in Hradec Králové
- Laser treatment clinical significant macular edema of diabetes mellitus 2nd typePublication without faculty affiliation
- Treatment of dyslipidemia typical for the patients with metabolic syndrom and DM type 22005 | First Faculty of Medicine
- Advanced forms of insulinotherapy patients with type 2 diabetes mellitus2009 | Publication without faculty affiliation
- Advance study - important step in prevention of cardiovascular complications in type II. diabetes mellitus2007 | Faculty of Medicine in Pilsen
- Advance study - important step in prevention of cardiovascular complications in type II. diabetes mellitus2007 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Mortalita a morbidita u pacientů s renálním onemocněním při léčbě empagliflozinem a bezpečnost empagliflozinu u pacientů s postižením periferních tepen dolních končetin ve studii EMPA-REG OUTCOME (komentář)2018 | First Faculty of Medicine
- Celogenomová analýza kvantitativních znaků ve vztahu k dm 2. Typu u francouzsko-kanadských rodin s hypertenzíPublication without faculty affiliation
- Meal test for glucose-dependent insulinotropic peptide (GIP) in obese and type 2 diabetic patients2010 | First Faculty of Medicine
- Long-term acting insulin analogues in the treatment of diabetes mellitus. Part II: detemir2006 | Second Faculty of Medicine
- Komentář ke studii (Účinnost a bezpečnost fixní kombinace inzulinu degludek a liraglutidu v porovnání s intenzifikovaným inzulinovým režimem - studie DUAL VII)2018 | First Faculty of Medicine
- Komentář ke studii (Inzulin glargin 300 U/ml vs. inzulin degludek 100 U/ml v prvním head-to-head porovnání u pacientů s DM 2. typu bez předchozí léčby inzulinem - výsledky studie BRIGHT)2018 | First Faculty of Medicine
- Dietary interventions used in the management of type 2 diabetes mellitus2013 | First Faculty of Medicine
- Vliv aktivace PPAR-alfa podáváním fibrátu na inzulinovou senzitivitu a endokrinní funkci tukové tkáně u obézních pacientek s DM 2. typuPublication without faculty affiliation
- Začínáme s inzulínem2022 | Second Faculty of Medicine, Third Faculty of Medicine
